| Included studies (n) | Number of patients | Incidence (95% CI) | P value* | |
---|---|---|---|---|---|
With Regression | Total | ||||
Measurement | 38 | 1425 | 2219 | 63%(0·49–0·77) | 0.01 |
 Qualitative | 25 | 627 | 1314 | 54% (0·37–0·70) | |
 Quantitative | 13 | 798 | 905 | 81% (0·69–0·91) | |
Time period | 38 | 1425 | 2219 | 63%(0·49–0·77) | 0.87 |
 Before 2000 | 15 | 353 | 565 | 65% (0·55–0·75) | |
 2000–2009 | 11 | 280 | 530 | 57% (0·29–0·83) | |
 2010–2019 | 12 | 792 | 1124 | 66% (0·35–0·91) | |
Region | 38 | 1425 | 2219 | 63%(0·49–0·77) | 0.97 |
 Asia | 19 | 879 | 1309 | 63% (0·40–0·83) | |
 Europe | 14 | 459 | 756 | 65% (0·43–0·85) | |
 North America | 5 | 87 | 154 | 60% (0·22–0·92) | |
Study type | 30a | 1315 | 1965 | 65%(0·48–0·80) | 0.14 |
 RCT | 5 | 125 | 421 | 37% (0·00–0·88) | |
 Prospective | 20 | 588 | 882 | 67% (0·57–0·77) | |
 Retrospective | 5 | 602 | 662 | 84% (0·65–0·97) | |
LDH level | 29b | 1241 | 1667 | 72% (0·58–0·84) | 0.17 |
 Single | 22 | 1103 | 1340 | 78% (0·67–0·87) | |
 Single/multiple | 7 | 138 | 327 | 51% (0·17–0·86) | |
Imaging method | 37c | 1416 | 2208 | 63%(0·48–0·76) | 0.97 |
 CT | 8 | 202 | 343 | 63% (0·46–0·79) | |
 MRI | 29 | 1214 | 1865 | 63% (0·45–0·79) | |
Countingd | 38 | 1425 | 2219 | 63%(0·49–0·77) | 0.33 |
 A | 30 | 1279 | 2018 | 61% (0·44–0·77) | |
 B | 8 | 146 | 201 | 72% (0·59–0·83) |